Rocaglamide and silvestrol: a long story from anti-tumor to anti-coronavirus compounds
Author:
Affiliation:
1. Institute of Organic Chemistry
2. Leibniz University Hannover
3. 30167 Hannover
4. Germany
5. Department of Molecular and Medical Virology
6. Ruhr-University Bochum
7. 44801 Bochum
Abstract
The flavagline silvestrol is a potential candidate against viral infections including COVID-19.
Funder
Bundesministerium für Bildung und Forschung
Publisher
Royal Society of Chemistry (RSC)
Subject
Organic Chemistry,Drug Discovery,Biochemistry
Link
http://pubs.rsc.org/en/content/articlepdf/2021/NP/D0NP00024H
Reference39 articles.
1. Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery
2. Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization.
3. mTOR-targeted therapy of cancer with rapamycin derivatives
4. PI3K and mTOR inhibitors—a new generation of targeted anticancer agents
5. Targeting the mTOR kinase domain: the second generation of mTOR inhibitors
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Amidino-rocaglates (ADRs), a class of synthetic rocaglates, are potent inhibitors of SARS-CoV-2 replication through inhibition of viral protein synthesis;Antiviral Research;2024-10
2. Identification of Rocaglate Acyl Sulfamides as Selective Inhibitors of Glioblastoma Stem Cells;ACS Central Science;2024-08-08
3. Silvestrol, a potent anticancer agent with unfavourable pharmacokinetics: Current knowledge on its pharmacological properties and future directions for the development of novel drugs;Biomedicine & Pharmacotherapy;2024-08
4. Screening and Lead Generation Techniques for RNA Binders;Methods and Principles in Medicinal Chemistry;2024-07-05
5. Silvestrol alleviates glioblastoma progression through ERK pathway modulation and MANBA and NRG-1 expression;BIOCELL;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3